IQVIA Logo
5148_Abstract digital technology background

Services

Discovery Sciences

Clinical success doesn't begin in therapeutic development. It begins in discovery.
Home / Services / Discovery Sciences

The decisions that shape clinical outcomes are often made long before a protocol is written, a patient is enrolled or a trial begins. They are made when a hypothesis is created, targets are selected and biological mechanisms are prioritized for efficacy and safety considerations.

At IQVIA Laboratories Discovery Sciences, we believe drug discovery begins with rational possibility and ends with success for the patient.

Our Drug Discovery Services

We challenge the orthodoxy of drug development, which separates discovery and the clinic. Our clinic-first approach combines drug-hunter expertise, human-centric biology, innovation, advanced technologies and AI-assisted insights to guide better decisions earlier.

5151_Abstract-pill-fill
Design and Developability

We utilize our 20 years of expertise and a vast repository of preclinical and clinical data to optimize candidate design and progression.

LEARN MORE

178_Female-scientist-pill-fill
Disease Biology

Our therapeutic expertise enables us to quickly assess the effectiveness of drug action or target modulation in the right disease context.

LEARN MORE

3842_Scientist-working-pill-fill
Human Safety NAMs

Our new approach methodologies (NAMs) are designed to deliver scalable, reproducible results with increased human relevance. Our experts can recommend where NAMs can be effectively applied, reducing reliance on traditional animal models while maintaining scientific rigor.

LEARN MORE

Transforming the probability of therapeutic success.

By integrating patient need, disease biology, broad modality options clinical translation and predictive insights from the start, we help identify the right therapy for the right indication aligning with patient selection, advancing candidates with greater confidence and a clearer path to clinical success.

Through clinically relevant science and experienced leadership, we help organizations challenge their assumptions, reduce risk and focus resources where they can have the greatest impact.

 

Tracking record of supporting clients in generating

 

>100

preclinical candidates delivered since 2000

54

Candidates reaching Phase I

36

Candidates reaching Phase II (POC)

4

Drugs approved and marketed by our clients

500+

patients

~500

publications

900+

Scientific experts delivering cutting-edge scientific and regulatory support.

Because drug discovery is not simply about finding what works in the lab.

It is about identifying what has the greatest potential to succeed for patients, utilizing data and known risk identifiers to advance programs with unprecedented speed and efficiency.

91%

Hit ID success rate

83%

Lead optimization success rate

84%

Hit-to-lead success rate

91%

Hit ID success rate

83%

Lead optimization success rate

84%

Hit-to-lead success rate

Browse Drug Discovery Services

Explore our comprehensive therapeutic area expertise across multiple disease areas.


Hit ID Hit to Lead Oncology Neuroscience Small Molecule Large Molecule Immunology Rare Disease IND-Enabling Safety Early De-risking

Related Services

card-3259_man in laboratory with tablet for medical analysis
Protein Sciences
Learn more
card-3234_Liquid drop from pipette to test tube
Antibody Libraries
Learn more
card-3229_test tubes for testing
In Vitro Immunology
Learn more
card-3259_man in laboratory with tablet for medical analysis
Additional Specialty Testing Services
Learn more
3842_Scientist working in the Laboratory
Human Safety NAMs
Learn more